Epigenetic mechanisms and non-coding rnas in osteoarthritis

Current Rheumatology Reports

Volumn 15, Issue 9, 2013, Pages

  Barter, Matt J ^a   Young, David A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cartilage; Chondrocyte; Chromatin; CpG; Dna methylation; Epigenetic; Hdac; HDAC inhibitor; Histone; Long non coding RNA; Microrna; Mir 140; Non coding RNA; Osteoarthritis; Sirt1; SOX9

Indexed keywords

UNTRANSLATED RNA; CHROMATIN;

ARTICLE; CARTILAGE CELL; CHONDROPATHY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DRUG TARGETING; EPIGENETICS; GENE EXPRESSION REGULATION; GENE SILENCING; HISTONE MODIFICATION; HUMAN; NONHUMAN; OSTEOARTHRITIS; PHENOTYPE; CHROMATIN; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY;

CHONDROCYTES; CHROMATIN; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OSTEOARTHRITIS; RNA, UNTRANSLATED;

EID: 84895917052     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-013-0353-z     Document Type: Article

References (108)

1. Arden N, Nevitt MC. Osteoarthritis: Epidemiology. Best Pract Res Clin Rheumatol. 2006;20(1):3-25 (Pubitemid 43230460)
2. Loeser R. Molecular mechanisms of cartilage destruction in osteoarthritis. Biochem J. 2008;8(4):303-6
3. Rowan AD, Litherland GJ, Hui W, Milner JM. Metalloproteases as potential therapeutic targets in arthritis treatment. Expert Opin Ther Targets. 2008;12(1):1-18 (Pubitemid 351247158)
4. Jones PA. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13(7):484-92
5. Blackledge NP, Klose R. CpG island chromatin: A platform for gene regulation. Epigenetics. 2011;6(2):147-52
6. Consortium EP, Dunham I, Kundaje A. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489 (7414):57-74. This is a landmark paper which defines the transcriptional landscape of the human genome
7. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011;25(10):1010-22
8. Cedar H, Bergman Y. Programming of DNA methylation patterns. Annu Rev Biochem. 2012;81:97-117
9. Sesselmann S, Soder S, Voigt R, et al. DNA methylation is not responsible for p21WAF1/CIP1 down-regulation in osteoarthritic chondrocytes. Osteoarthr Cartil. 2009;17(4):507-12
10. Barter MJ, Bui C, Young DA. Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthr Cartil. 2012;20(5):339-49
11. Poschl E, Fidler A, Schmidt B, et al. DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage. Ann Rheum Dis. 2005;64(3):477-80 (Pubitemid 40283064)
12. Zimmermann P, Boeuf S, Dickhut A, et al. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum. 2008;58(9):2743-53
13. Kim,KI,YSPark,GIIm.Changesintheepigeneticstatusof theSOX- 9 promoter in human osteoarthritic cartilage. JBoneMiner Res, 2012
14. Roach HI, Yamada N, Cheung KS, et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 2005;52(10):3110-24 (Pubitemid 41447092)
15. Bui C, Barter MJ, Scott JL, et al. cAMP response elementbinding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis. FASEB J. 2012;26(7):3000-11. This paper is the first to detail how a CpG change in osteoarthritis can impact on expression of the important collagenase MMP13
16. Hashimoto K, Otero M, Imagawa K, et al. Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin- 1beta (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J Biol Chem. 2013;288 (14):10061-72
17. de Andres, MC, K Imagawa, K Hashimoto, et al. Loss of methylation in CpG sites in the NF-kappaB enhancer elements of iNOS is responsible for gene induction in human articular chondrocytes. Arthritis Rheum, 2012
18. Hashimoto K, Oreffo RO, Gibson MB, et al. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum. 2009;60(11):3303-13
19. Iliopoulos D, Malizos KN, Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis. 2007;66(12):1616-21 (Pubitemid 350205450)
20. Delgado-Calle J, Fernandez AF, Sainz J, et al. Genome-wide profiling of bone reveals differentially methylated regions in osteoporosis and osteoarthritis. Arthritis Rheum. 2013;65(1):197-205
21. Reynard LN, Bui C, Canty-Laird EG, et al. Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum Mol Genet. 2011;20(17):3450-60. The paper links DNA methylation to differential allelic expression of an important OA-associated gene
22. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381-95
23. Clayton AL, Hazzalin CA, Mahadevan LC. Enhanced histone acetylation and transcription: A dynamic perspective. Mol Cell. 2006;23(3):289-96 (Pubitemid 44128853)
24. Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12-27
25. Gregoretti IV, Lee YM, Goodson HV. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol. 2004;338(1):17-31 (Pubitemid 38429783)
26. Inoue T, Hiratsuka M, Osaki M, Oshimura M. The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle. 2007;6(9):1011-8 (Pubitemid 46708571)
27. Lee JS, Smith E, Shilatifard A. The language of histone crosstalk. Cell. 2010;142(5):682-5
28. Tan M, Luo H, Lee S, et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell. 2011;146(6):1016-28
29. Huber LC, Brock M, Hemmatazad H, et al. Histone deacetylase/ acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 2007;56 (4):1087-93 (Pubitemid 46608633)
30. Higashiyama R, Miyaki S, Yamashita S, et al. Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. Mod Rheumatol. 2010;20(1):11-7
31. Hong S, Derfoul A, Pereira-Mouries L, Hall DJ. A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J. 2009;23(10):3539-52
32. Chen WP, Bao JP, Hu PF, et al. Alleviation of osteoarthritis by trichostatin a, a histone deacetylase inhibitor, in experimental osteoarthritis. Mol Biol Rep. 2010;37(8):3967-72
33. Chung YL, Lee MY, Wang AJ, Yao LF. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol Ther. 2003;8(5):707-17
34. Lin HS, Hu CY, Chan HY, et al. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collageninduced arthritis in rodents. Br J Pharmacol. 2007;150(7):862-72
35. Nishida K, Komiyama T, Miyazawa S, et al. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression. Arthritis Rheum. 2004;50(10):3365-76 (Pubitemid 39372015)
36. Chabane N, Zayed N, Afif H, et al. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthr Cartil. 2008;16 (10):1267-74
37. Young DA, Lakey RL, Pennington CJ, et al. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis ResTher. 2005;7(3):R503-12
38. Wang X, Song Y, Jacobi JL, Tuan RS. Inhibition of histone deacetylases antagonized FGF2 and IL-1beta effects on MMP expression in human articular chondrocytes. Growth Factors. 2009;27(1):40-9
39. Furumatsu T, Tsuda M, Yoshida K, et al. Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem. 2005;280(42):35203-8 (Pubitemid 41532707)
40. Huh YH, Ryu JH, Chun JS. Regulation of type II collagen expression by histone deacetylase in articular chondrocytes. J Biol Chem. 2007;282(23):17123- 31
41. Zayed N, El Mansouri FE, Chabane N, et al. Valproic acid suppresses interleukin-1ss-induced microsomal prostaglandin E2 synthase-1 expression in chondrocytes through upregulation of NAB1. J Rheumatol. 2011;38(3):492-502
42. Saito T, Nishida K, Furumatsu T, et al. Histone deacetylase inhibitors suppress mechanical stress-induced expression of RUNX-2 and ADAMTS-5 through the inhibition of the MAPK signaling pathway in cultured human chondrocytes. Osteoarthr Cartil. 2013;21(1):165-74
43. Gagarina V, Gabay O, Dvir-Ginzberg M, et al. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum. 2010;62(5):1383-92
44. Hong EH, Lee SJ, Kim JS, et al. Ionizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinase. J Biol Chem. 2010;285(2):1283-95
45. TakayamaK,IshidaK,MatsushitaT,etal.SIRT1regulationofapoptosis of human chondrocytes. Arthritis Rheum. 2009;60(9):2731-40
46. Dvir-Ginzberg M, Gagarina V, Lee EJ, Hall DJ. Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. J Biol Chem. 2008;283(52):36300-10
47. Fujita N, Matsushita T, Ishida K, et al. Potential involvement of SIRT1 in the pathogenesis of osteoarthritis through the modulation of chondrocyte gene expressions. J Orthop Res. 2011;29(4):511-5
48. Gabay O, Oppenhiemer H, Meir H, et al. Increased apoptotic chondrocytes in articular cartilage from adult heterozygous SirT1 mice. Ann Rheum Dis. 2012;71(4):613-6. SirT1 has been linked to chondrocyte function; here, the authors confirm a role of SirT1 in regulating chondrocyte apoptosis in vivo
49. Lei M, Wang JG, Xiao DM, et al. Resveratrol inhibits interleukin 1beta-mediatedinducible nitric oxidesynthaseexpressionin articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-kappaBactivity. Eur J Pharmacol. 2012;674(2-3):73-9
50. Matsushita, T, H Sasaki, K Takayama, et al. The overexpression of SIRT1 inhibited osteoarthritic gene expression changes induced by interleukin-1beta in human chondrocytes. J Orthop Res, 2012
51. Moon, MH, JK Jeong, YJ Lee, et al. SIRT1, a class III histone deacetylase, regulates TNF-alpha-induced inflammation in human chondrocytes. Osteoarthritis Cartilage, 2012
52. El Mansouri FE, Chabane N, Zayed N, et al. Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes. Arthritis Rheum. 2011;63(1):168-79
53. Castano Betancourt MC, Cailotto F, Kerkhof HJ, et al. Genomewide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci U S A. 2012;109(21):8218-23. This study is the first to provide a direct link between an histone methyltransferase and hip osteoarthriti
54. Harries LW. Long non-coding RNAs and human disease. Biochem Soc Trans. 2012;40(4):902-6
55. Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101-8
56. DerrienT,JohnsonR,BussottiG, etal.TheGENCODEv7catalogof human long noncoding RNAs:Analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775-89. This paper, which is part of ENCODE, defines and catalogues long noncoding RNAs in humans
57. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011;12(2):99-110
58. Czech B, Hannon GJ. Small RNA sorting: Matchmaking for argonautes. Nat Rev Genet. 2010;12(1):19-31
59. Grimson A, Farh KK, Johnston WK, et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27(1):91-105 (Pubitemid 46991392)
60. Chi SW, GJ Hannon RB. Darnell, An alternative mode of microRNA target recognition. Nat Struct Mol Biol. 2012;19 (3):321-7
61. Neilsen CT, Goodall GJ, Bracken CP. IsomiRs-the overlooked repertoire in the dynamic microRNAome. Trends Genet. 2012;28 (11):544-9
62. Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev. 2011;91(3):827-87
63. Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: The rosetta stone of a hidden RNA language? Cell. 2011;146(3):353-8
64. Pasquinelli AE. MicroRNAs and their targets: Recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13(4):271-82
65. Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012;148(6):1172-87
66. Guil S, Esteller M. Cis-acting noncoding RNAs: Friends and foes. Nat Struct Mol Biol. 2012;19(11):1068-75
67. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145-66
68. Dudek KA, Lafont JE, Martinez-Sanchez A, Murphy CL. Type II collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes. J Biol Chem. 2010;285(32):24381-7
69. Jones SW, Watkins G, Le Good N, et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthr Cartil. 2009;17(4):464-72
70. Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One. 2008;3(11):e3740
71. Diaz-Prado S, Cicione C, Muinos-Lopez E, et al. Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskelet Disord. 2012;13:144
72. Nakasa T, Miyaki S, Okubo A, et al. Expression of microRNA- 146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008;58(5):1284-92 (Pubitemid 351705917)
73. Wang Y, Jiang XL, Yang SC, et al. MicroRNAs in the regulation of interfacial behaviors of MSCs cultured on microgrooved surface pattern. Biomaterials. 2011;32(35):9207-17
74. Li J,HuangJ,Dai L, et al.miR-146a,an IL-1beta responsivemiRNA, inducesvascularendothelialgrowthfactorandchondrocyteapoptosis by targeting Smad4.Arthritis Res Ther. 2012;14(2):R75
75. Lin, L, Q Shen, C Zhang, et al. Assessment of the profiling MicroRNA expression of differentiated and dedifferentiated human adult articular chondrocytes. J Orthop Res, 2011
76. Murata K, Yoshitomi H, Tanida S, et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2010;12(3):R86
77. Yamasaki K,NakasaT,Miyaki S, et al.Expression ofMicroRNA-146a in osteoarthritis cartilage.Arthritis Rheum. 2009;60(4):1035-41
78. Okuhara, A, T Nakasa, H Shibuya, et al. Changes in microRNA expression in peripheral mononuclear cells according to the progression of osteoarthritis. Mod Rheumatol, 2011
79. Miyaki S, Nakasa T, Otsuki S, et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 2009;60(9):2723-30
80. Miyaki S, Sato T, Inoue A, et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 2010;24(11):1173-85. The first paper to show that a single miR, miR-140, could regulate skeletal development and OA onset
81. Nakamura Y, Inloes JB, Katagiri T, Kobayashi T. Chondrocytespecific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling. Mol Cell Biol. 2011;31(14):3019-28
82. Tuddenham L, Wheeler G, Ntounia-Fousara S, et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 2006;580(17):4214-7 (Pubitemid 44037596)
83. Wienholds E, KloostermanWP,Miska E, et al.MicroRNA expression inzebrafishembryonicdevelopment. Science.2005;309(5732):310-1
84. Swingler, TE, G Wheeler, V Carmont, et al. The expression and functionofmicroRNAsinchondrogenesisandosteoarthritis.Arthritis Rheum, 2011
85. Buechli, ME, J Lamarre, TG Koch. MicroRNA-140 expression during chondrogenic differentiation of equine cord blood-derived mesenchymal stromal cells. Stem Cells Dev, 2012
86. Yamashita S, Miyaki S, Kato Y, et al. L-Sox5 and Sox6 proteins enhance chondrogenic miR-140microRNA expression by strengthening dimeric Sox9 activity. J Biol Chem. 2012;287(26):22206-15
87. Nakamura Y, He X, Kato H, et al. Sox9 is upstream of microRNA- 140 in cartilage. Appl Biochem Biotechnol. 2011;166(1):64-71
88. Yang J, Qin S, Yi C, et al. MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation. FEBS Lett. 2011;585(19):2992-7
89. HeX,YanYL, DelaurierA, Postlethwait JH.Observation ofmiRNA Gene Expression in Zebrafish Embryos by In Situ Hybridization to MicroRNAPrimary Transcripts. Zebrafish. 2011;8(1):1-8
90. Pando R, Even-Zohar N, Shtaif B, et al. MicroRNAs in the growth plate are responsive to nutritional cues: association between miR- 140 and SIRT1. J Nutr Biochem. 2012;23(11):1474-81
91. van der Kraan PM, Goumans MJ, Blaney Davidson E, ten Dijke P. Age-dependent alteration of TGF-beta signalling in osteoarthritis. Cell Tissue Res. 2012;347(1):257-65
92. Li N, Cui J,Duan X, et al. Suppression of type I collagen expression by miR-29b via PI3K, Akt, and Sp1 pathway in human Tenon's fibroblasts. Invest Ophthalmol Vis Sci. 2012;53(3):1670-8
93. Li Z, Hassan MQ, Jafferji M, et al. Biological functions of miR- 29b contribute to positive regulation of osteoblast differentiation. J Biol Chem. 2009;284(23):15676-84
94. Yan C, Wang Y, Shen XY, et al. MicroRNA regulation associated chondrogenesis of mouseMSCs grown on polyhydroxyalkanoates. Biomaterials. 2011;32(27):6435-44
95. Steck E, Boeuf S, Gabler J, et al. Regulation of H19 and its encoded microRNA-675 in osteoarthritis and under anabolic and catabolic in vitro conditions. J Mol Med (Berl). 2012;90(10):1185-95
96. Dai L, Zhang X, Hu X, et al. Silencing of microRNA-101 prevents IL-1beta-induced extracellular matrix degradation in chondrocytes. Arthritis Res Ther. 2012;14(6):R268
97. Xu J, Kang Y, Liao WM, Yu L. MiR-194 regulates chondrogenic differentiation of human adipose-derived stem cells by targeting Sox5. PLoS One. 2012;7(3):e31861
98. Song, J, M Lee, D Kim, et al. MicroRNA-181b regulates articular chondrocytes differentiation and cartilage integrity. Biochem Biophys Res Commun, 2013
99. Abouheif MM, Nakasa T, Shibuya H, et al. Silencing microRNA- 34a inhibits chondrocyte apoptosis in a rat osteoarthritis model in vitro. Rheumatology (Oxford). 2010;49(11):2054-60
100. Kim, D, J Song, SKim, et al.MicroRNA-34amodulates cytoskeletal dynamicsthroughregulatingRhoA/Rac1crosstalkinchondroblasts.J Biol Chem, 2012
101. Akhtar,N,HaqqiTM.MicroRNA-199a* regulates the expression of cyclooxygenase-2 in human chondrocytes.AnnRheumDis, 2012
102. Akhtar N, Rasheed Z, Ramamurthy S, et al. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum. 2010;62(5):1361-71
103. Zhang L, Yang M, Marks P, et al. Serum non-coding RNAs as biomarkers for osteoarthritis progression after ACL injury. Osteoarthr Cartil. 2012;20(12):1631-7
104. Maass PG, Rump A, Schulz H, et al.Amisplaced lncRNA causes brachydactyly in humans. J Clin Invest. 2012;122(11):3990-4002. The first paper to demonstrate that a lncRNA could be important for skeletal development
105. Xu Y, Barter MJ, Swan DC, et al. Comparison of osteoarthritis and normal hip cartilage transcriptomes using RNA-seq reveals new candidate gene targets and associated pathways. Osteoarthr Cartil. 2012;20(1):S43
106. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulatingmicroRNAs independent of vesicles inhumanplasma. ProcNatlAcadSciUSA.2011;108(12):5003-8.A paperwhich redefines howmiR circulate in the bloodstream
107. Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by highdensity lipoproteins. Nat Cell Biol. 2011;13(4):423-33
108. de Groote ML, Verschure PJ, Rots MG. Epigenetic editing: Targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Res. 2012;40(21):10596-613. Identification of genes and epigenetic marks involved in osteoarthritis is important and this paper describes mechanisms in which those marks can be modulated to control gene expression